Is Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Good Position To Invest In Growth?

Simply Wall StMay 8 08:28 ET

Earnings Preview: ARCT to Report Financial Results Post-market on May 12

Moomoo NewsMay 6 21:00 ET

Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline

Yahoo FinanceMay 5 10:00 ET

Express News | Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025

ReutersApr 22 16:01 ET

Arcturus Therapeutics (ARCT) Gets a Hold From Leerink Partners

TipRanksApr 17 07:15 ET · Ratings

Arcturus Therapeutics: Promising Phase II Prospects for ARCT-032 in Cystic Fibrosis Amidst Regulatory Approvals

TipRanksApr 16 07:25 ET